ChristineMarieHolmMD

Journal Articles

• The Platelet-Derived Growth Factor B Receptor and Flk-I are Expressed in Non-Small Cell Tumor Cell lines  
  • Holm, C., McConville, G.S., Gingetis, D., and Kazlaukas, A, International J Oncology, 9/1996
• Hydroxyurea Potentiation of the Antineplastic Activity of Cyclophosphamide and 4' - (9- Acridinylamino) Methane - Sufon-m-Anisidide (M-AMSA) in the Brown Norway Rat My...  
  Vaughan, W.P., Holm, C., Cordel, K, Can Chemo Pharm, 1/1/1989
• Differential Requirements of DNA Replication for Cytotoxicity of DNA Topoisomerase I AND II Inhibitors in Chineses Hamsters DC3F Cells  
  Holm, C., Covey, J.M., Kerrigan, D., and Pommier, Y, Can Res, 1/1/1989

Books/Book Chapters

• Hematology/Oncology Secrets 
  Chapter: Polycythemic States 
  • Holm C., Wood, MEditors: Wood, M. Hanely & Belfus, Philadelphia1999
• Hematology/Oncology Secrets. 
  Chapter: Polycythemic States 
  Holm C., Wood, M.Editors: Wood, M..Hanely & Belfus, Inc., Philadelphia, PA1993
• Current Therapy in Oncology 
  Chapter: Prostrate Cancer 
  Glode, L.M., Holm, C.Editors: Foley, F., Vose, J.R, Armitage, J.O..W.B. Saunders, Philadelphia, PA1992
• Topoisomerases in Cancer 
  Chapter: Protection by DNA Synthesis Inhibition Against Cell Killing by Topoisomerase Blocking Drugs. 
  Holm, C., Covey, J.M., Kerrigan, D., Kohn, KW., Pommier, Y.Oxford Press1990
• Join now to see all

Abstracts/Posters

• Effects of DNA Synthesis Inhibition by Aphidicolin upon the Cytotoxicity and DNA Strand Breaks Produced by the Topoisomerase I and II Inhibitors: Campthothecin, VP 16 ...
  Holm, C, Covey, J, Kerrigan, D., Pommier Y, Second Conference on DNA Topoisomerases in Cancer Chemotherapy, New York, NY, 1/1/1988
• Sequence Dependent Synergy Between Hydroxyurea (HU) and the Topoisomerase inhibitors 4' -(9- acrindinylamino) methanesulfon-m-anisidide (mAMSA) and Etoposide (VPI6) "i...
  Vaughn, W.P., Holm, C., Cordel, K., First Conference on DNA Topoisomerases in Cancer Chemotherapy, New York, NY, 1/1/1986

Lectures

• Oncologic Emergencies 
  Humbolt and Des Moines General Hospital, 1996, 1997; Dubuque, IA, 2016 - 1/1/2005
• Post Menopause Hormone Replacement: Risk vs. Benefits 
  1/1/2003
• Breast Cancer 
  Ames, 1994; Des Moines General Hospital, 1997; Twin Falls and Burley, ID, 2001 - 1/1/2001
• Pain Management 
  1/1/2001
• Principles Pain Management 
  1/1/2000
• Tamoxfen prevention trial, When node with Breast Cancer needs treatment 
  1/1/1999
• Hemolytic Anemia 
  Univ. of Osteopathic Medicine & Health Sciences, 1995, 1996, 1997, 1998 - 1/1/1998
• Plasma Cell Dyscrasias 
  Univ. of Osteopathic Medicine & Health Sciences, 1995, 1996, 1997, 1998 - 1/1/1998
• Myelodysplastic Syndromes 
  University of Osteopathic Med. & Health Sciences, 1996, 1997, 1998 - 1/1/1998
• Polycythemia Vera and Erythrocytosis 
  University of Osteopathic Med. & Health Sciences, 1996, 1997, 1998 - 1/1/1998
• Thrombophilia and the CV System 
  1/1/1998
• Thrombophilia 
  1/1/1998
• Heparin Associated Platelet Aggregation 
  1/1/1998
• Part A: Sort Tissue Sarcomas 
  1/1/1998
• Part B: Bone Tumors 
  1/1/1998
• Hypercalcemia 
  1/1/1998
• Lymphomas (NHL,HD) 
  University of Osteopathic Med. & Health Sciences, 1996, 1997 - 1/1/1997
• Pain Management Lectures 
  Mercy Clinics, Des Moines General Hospital & Humbolt - 1/1/1996
• Menopause and Breast Cancer 
  1/1/1994
• DNA Synthesis and Cytotoxicity of Topoisomerase Active Drugs 
  University of Nebraska Medical Center - 1/1/1990
• Enhancement of Etoposide (VPI6) Antineopatic Activity by Hydroxyurea 
  1/1/1986
• Join now to see all